Canna~Fangled Abstracts

The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window.

By October 16, 2017No Comments
Front Endocrinol (Lausanne). 2017 Oct 16;8:268. doi: 10.3389/fendo.2017.00268. eCollection 2017.

Abstract

PM 2 site 207BACKGROUND/AIMS:

We investigated the role of the endocannabinoid system (ECS) in the endometrium of unexplained infertility (UI) patients, and effect of anandamide (AEA) on leukemia inhibitory factor (LIF).

METHODS:

Patients were divided into UI and control groups. Endometrium samples were collected at the midluteal phase. Levels of cannabinoid type 1 (CB1), fatty acid amide hydrolase (FAAH), and LIF were examined. LIF productions were measured after AEA, CB1 antagonist AM251, and CB2 antagonist AM630 stimulation.

RESULTS:

Rates of available embryo, successful implantation and pregnancy, and the endometrial thickness of UI group were significantly lower than control, suggesting uterine receptivity was decreased in UI group. FAAH and LIF levels were significantly decreased, whereas endometrial CB1 was slightly increased in UI group. LIF production was promoted by low amount of AEA administration (1-10 μM), while the promotion was reduced by higher concentration of AEA (50 μM). LIF levels were decreased by AM251 or AM630, compared with AEA alone. Expressions of FAAH and LIF were closely associated with uterus receptivity and implantation rate of UI patients. Different concentrations of AEA could stimulate dynamic changes in LIF production.

CONCLUSION:

Our data indicated the important role of the ECS in human fertility, which may promote new strategies for successful implantation and treatments for reproductive diseases.

KEYWORDS:

anandamide; endocannabinoid system; endometrial receptivity; fatty acid amide hydrolase; leukemia inhibitory factor; unexplained infertility

PMID: 29085337
PMCID: PMC5650704
DOI: 10.3389/fendo.2017.00268
twin memes II